WuXi AppTec Co., Ltd. (OTCMKTS:WUXIF – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 1,146,990 shares, a growth of 84.2% from the June 30th total of 622,696 shares. Based on an average daily volume of 18,123 shares, the short-interest ratio is presently 63.3 days.
WuXi AppTec Trading Down 0.0%
OTCMKTS WUXIF opened at $21.55 on Thursday. The company has a 50 day moving average of $18.62 and a 200-day moving average of $16.05. WuXi AppTec has a 1-year low of $13.54 and a 1-year high of $22.70.
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. The company provides end-to-end solutions spanning discovery biology, medicinal chemistry, preclinical safety assessment, clinical trial support, and large-scale manufacturing of small molecules, biologics and advanced therapies. By integrating scientific expertise with state-of-the-art laboratory and production facilities, WuXi AppTec enables clients to accelerate the development of new treatments while managing time and cost pressures.
Key service offerings include custom synthesis and process research for active pharmaceutical ingredients (APIs), biologics development and manufacturing, cell line development, gene therapy support, as well as comprehensive analytical and testing services.
Featured Stories
- Five stocks we like better than WuXi AppTec
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
